Free Trial

Brooklyn ImmunoTherapeutics (BTX) SEC Filings & 10K Form

Brooklyn ImmunoTherapeutics logo
$6.42 +0.02 (+0.31%)
As of 05/2/2025 03:59 PM Eastern

Recent Brooklyn ImmunoTherapeutics SEC Filings

DateFilerForm TypeView
04/29/2025
11:15 PM
Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
04/16/2025
3:30 PM
Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2025
4:05 PM
Ernexa Therapeutics Inc. (Filer)
Ernexa Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
04/04/2025
9:54 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
9:55 AM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
04/03/2025
4:17 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
04/03/2025
7:55 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 424B3
11/17/2024
11:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form EFFECT
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form ARS
09/27/2024
3:47 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form PRE 14A
09/27/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:14 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Elon’s Terrifying Warning Forces Trump To Take Action (Ad)

Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...

(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BTX) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners